Opdivo May Improve Survival in Mesothelioma That Progressed on First-Line Chemotherapy, Opdivo May Improve Survival in Mesothelioma That Progressed on First-Line Chemotherapy – Immunotherapy with Opdivo (nivolumab) may be a beneficial treatment for patients with malignant mesothelioma whose disease progressed on first-line therapy, trial results demonstrated.
“Immunotherapy had demonstrated potentially useful activity in patients with mesothelioma who had growth of their tumors after initial (first-line) chemotherapy,” said Dean A. Fennell, a professor of thoracic medical oncology and director of a mesothelioma research program at the University of Leicester in the United Kingdom, in an interview with CURE®. “No treatment to date (has) been licensed for the treatment of these patients. This is therefore a clinical setting of unmet need.”
Findings from the CONFIRM trial were published in Lancet Oncology, which represents “the first phase 3 clinical trial to have demonstrated an improvement in survival for patients with relapsed mesothelioma,” said Fennell, who was one of the researchers on this trial.
Although Opdivo on its own may provide an effective treatment option for patients with malignant mesothelioma, it has not been approved by the Food and Drug Administration (FDA) for this particular use. Of note, Opdivo has been approved with another immunotherapy for patients with malignant mesothelioma.
“It is important to note that immunotherapy with (Opdivo) and ipilimumab (Yervoy) was approved by the FDA,” Fennell said. “This treatment is therefore a first-line option for patients worldwide. As with other cancers, immunotherapy is likely to find its home for patients in the first-line setting.”
In the CONFIRM trial, researchers assessed data from 332 patients with relapsed, malignant mesothelioma. These patients were randomly assigned treatment with Opdivo (221 patients; median age, 70 years; 76% men) or placebo (111 patients, median age, 71 years; 78% men). Both groups received treatment every two weeks until disease progression or a maximum of 12 months, whichever occurred first.
The main objectives of this trial were to assess progression-free survival (time from treatment assignment to disease progression or death) and overall survival (time from treatment assignment to all-cause death). Patients were followed up for a median of 11.6 months.
During the trial, patients received a median of six doses of Opdivo and four doses of placebo. Patients assigned Opdivo had a median progression-free survival of three months compared with 1.8 months in those assigned placebo. In addition, median overall survival was 10.2 months in the Opdivo group versus 6.9 months in the placebo group.
The most commonly reported severe or worse side effects related to the treatment in patients assigned either Opdivo or placebo included diarrhea (3% versus 2%, respectively) and infusion-related reactions (3% versus 0%, respectively). Serious side effects occurred in 41% of patients in the Opdivo group compared with 44% in the placebo group. No deaths related to the treatment occurred in either group.
“The toxicity of (Opdivo) was in line with expected, licensed therapy,” Fennell said. “(Side effects) due to (Opdivo) were manageable. It should be noted that overall, the serious (side effect) rate was higher for patients receiving placebo rather than (Opdivo). This reflects the general safety of this treatment that was well tolerated.”
Despite these important findings, Fennell mentioned that more research is needed in this area.
“It’s essential that we understand why patients with mesothelioma respond at all to immunotherapy,” he said. “Understanding this could help us personalize therapy (improve cost effectiveness and efficacy); develop better combinations to improve the level of expected benefit for patients; and develop immunotherapies that can overcome resistance that develops with first-line therapy.”
Fennell noted that new treatments for patients with mesothelioma represent an exciting time in this space.
“New treatments for mesothelioma are being reported at an increased rate, which is very welcome with associated approvements in clinical outcome,” he concluded. “This is very welcome and is set to continue as we increase our understanding of biology and evaluate more new exciting treatments, particularly in the relapsed setting where there remains a lack of FDA-approved therapy.”
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Insurance Gas/Electricity Loans Mortgage Attorney Lawyer Donate Conference Call Degree Credit Treatment Software Classes Recovery Trading Rehab Hosting Transfer Cord Blood Claim compensation mesothelioma mesothelioma attorney Houston car accident lawyer moreno valley can you sue a doctor for wrong diagnosis doctorate in security top online doctoral programs in business educational leadership doctoral programs online car accident doctor atlanta car accident doctor atlanta accident attorney rancho Cucamonga truck accident attorney san Antonio ONLINE BUSINESS DEGREE PROGRAMS ACCREDITED online accredited psychology degree masters degree in human resources online public administration masters degree online bitcoin merchant account bitcoin merchant services compare car insurance auto insurance troyA Tax Attorney, A Tax Lawyer, Affordable Tax Attorney, Affordable Tax Lawyer, alabama lawyer mesothelioma, asbestos attorney, asbestos cancer attorney, asbestos claim, asbestos lawsuit, asbestos lawyer, asbestos litigation, Attorney, Attorney For Irs Issues, Attorney Irs Tax, Attorney Tax Law, Attorney To Help With Irs, auto insurance, auto insurance quote, automobile insurance, Back Tax Attorney, Back Taxes Lawyer, Bankruptcy Tax Attorney, Best Irs Tax Lawyer, Best Tax Relief Attorneys, California Franchise Tax Board Attorney, car cheapest insurance, car donation, car donation california, car donation in california, car donation in jersey new, car donation in massachusetts, car donation san jose, car donation virginia, Car Insurance, car insurance online, car insurance online quote, car insurance quote, car insurance quotes, cheap auto insurance, cheap car insurance, cheap car insurance quote, cheap insurance, Cheap Tax Lawyer, cheapest car insurance, Dfw Tax Attorney, discount auto insurance, donate a car, donate car, donate car california, donate car charity, donate car sacramento, donate car salvation army, donate cars, donate my car, donate vehicle, donate your car, donate your car sacramento, donating car, Federal Tax Attorney, Find A Tax Attorney, Find A Tax Lawyer, Ftb Attorney, Gas Electicity, Get A Tax Lawyer, Good Tax Attorney Near Me, Health, houston asbestos lawyer, I Need A Tax Attorney, illinois asbestos attorney, illinois mesothelioma attorney, illinois mesothelioma lawyer, Income Tax Lawyers, Instant Tax Attorney, Insurance, insurance quote, insurance quotes, insurance rates, Irs Attorney, Irs Attorney Help, Irs Audit Attorneys Near Me, Irs Debt Attorney, Irs Defense Attorney, Irs Fraud Attorney, Irs Lawyer, Irs Lawyer Help, Irs Lawyer Near Me, Irs Legal Help, Irs Problems Tax Attorney, Irs Tax Attorney, Irs Tax Attorney Near Me, Irs Tax Attorneys In My Area, Irs Tax Help Attorney, Irs Tax Lawyer, Irs Tax Relief Attorneys, Irs Tax Relief Lawyer, Irs Tax Settlement Attorneys, Irs Whistleblower Lawyer, John Pontius Tax Law, Lawyer For Irs Debt, Lawyer For Tax Problems, Lawyers For Irs Issues, Lawyers For Tax Issues, Lawyers Tax, Legal Tax Lawyers, Loan, Local Irs Tax Attorney, Local Tax Lawyers, Local Tax Relief Lawyers, low cost insurance, Mesothelioma, mesothelioma attorney, mesothelioma attorney houston, mesothelioma attorney texas, mesothelioma attorneys, mesothelioma lawyer, mesothelioma lawyer houston, mesothelioma lawyers, mesothelioma litigation, Mortgage, National Tax Attorney, new york mesothelioma lawyers, Payroll Tax Attorney Near Me, Payroll Tax Lawyer, Personal Tax Lawyer Near Me, phoenix dui attorney, san diego car donation, State Tax Lawyers Near Me, Steven Leahy Tax Attorney, Tax Attorney, tax attorney columbus ohio, Tax Attorney For Back Taxes, Tax Attorney Help, Tax Attorney Office, Tax Attorneys For Irs, Tax Attorneys In My Area, Tax Audit Lawyer, Tax Bankruptcy Lawyer, Tax Court Attorney, Tax Criminal Lawyer, Tax Debt Attorney, Tax Debt Attorney Near Me, Tax Debt Lawyer, Tax Debt Lawyers Near Me, Tax Debt Relief Attorney Near Me, Tax Debt Relief Attorneys, Tax Debt Relief Lawyers, Tax Defense Attorney, Tax Defense Lawyer, Tax Evasion Attorney, Tax Help Attorney, Tax Help Lawyers, Tax Law Attorney, Tax Lawyers Around Me, Tax Legal Help, Tax Levy Attorney, Tax Lien Attorney, Tax Lien Lawyer Near Me, Tax Relief Attorney Near Me, Tax Relief Attorneys, Tax Relief Lawyer Near Me, Tax Relief Lawyers, Tax Relief Lawyers Near Me, Tax Settlement Attorney, Tax Settlement Lawyer, Taxation Lawyer, Taxattorneytampa, Taxes Lawyer Near Me, texas asbestos lawyer, texas mesothelioma attorney, Top Irs Attorneys, vehicle donations